Project Grant K08HL175196
Award Date 7/1/26
Completion Date 4/30/31
Dollars Obligated $154K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63103, USA
Similar Awards
- Federal Grant Award Summary Saint Louis University received a $617,477 Project Grant award from the National Heart, Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 16, 2026, with completion scheduled for April 30, 2030. The award funds research to identify mechanisms of plasmalogen dysregulation during sepsis and develop therapeutic interventions targeting this condition. The project investigates how oxidative stress during sepsis...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of California, Los Angeles a $1.56 million Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective July 15, 2026, with completion targeted for March 31, 2028. This award funds basic science research to elucidate the role of noncoding RNA—specifically long noncoding RNAs (lncRNAs) and micropeptides—in cardiovascular disease pathogenesis, with emphasis on lipid metabolism,...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Washington University a Project Grant totaling $169,140 effective July 1, 2026, through April 30, 2031, under the Cardiovascular Diseases Research program (CFDA 93.837). This award funds mechanistic research investigating immuno-metabolic drivers of chronic rejection following lung transplantation, specifically addressing bronchiolitis obliterans syndrome (BOS)—the major cause of death occurring one...
- Federal Grant Award Summary The University of Illinois Chicago received a $407,052 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through July 31, 2030. This award establishes a new T32 Postdoctoral Research Training Program in Lung Injury and Inflammation within the Division of Pulmonary, Critical Care, Sleep, and Allergy. The program builds upon the institution's...
- Federal Grant Award Summary The University of Illinois received a $1.64 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 2, 2025, with completion scheduled for May 31, 2029. This award funds basic research investigating inter-organelle communication mechanisms in hepatic lipid metabolism, specifically examining the regulatory roles of SEC16B, a scaffold protein located at the...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $167,705 Project Grant to The Washington University, Office of Sponsored Research Services, effective August 15, 2025, through July 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This award supports a five-year research and career development initiative led by Dr. Amit Bery focused on investigating how immunosuppressive neutrophils modulate alloimmune responses...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $133,436 to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This K99/R00 career development award supports Dr. Sri Karthika Shanmugam's transition to an independent academic position through a structured two-phase research and training program extending through July 31, 2027....
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $694,754 Project Grant to The Washington University, Office of Sponsored Research Services, effective August 1, 2025, through May 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This research initiative focuses on developing a mechanism-based precision medicine approach for treating cardiomyopathies by connecting molecular and cellular contractile dysfunction to patient...
- Federal Grant Award Summary The University of Illinois received a $796,189 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through June 30, 2029. The award funds research investigating chemokine receptor signaling and neutrophil phenotype dynamics during inflammatory lung injury. The project will define how distinct neutrophil subpopulations are trafficked and contribute to...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Icahn School of Medicine at Mount Sinai a $447,977 Project Grant effective September 1, 2025, through August 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). The Cardiovascular Science Training Program (CSTP) provides research training and mentorship to pre-doctoral and post-doctoral scientists pursuing independent careers in cardiovascular research. The program delivers...